ResearchMoz

Carfilzomib - Comprehensive patent search

Publisher Name » GenericsWeb
Published Date » 2012-05-12
No. Of Pages » N/A

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features:

  • Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified'below)
  • Patent identification, categorisation and interpretation
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims
  • Manual filtration of patents not relevant to generic development
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified:

1. Molecular Form
a) Molecule Patents
b) Salts, Hydrates & Solvates
c) Polymorphic Forms
d) Other Molecular Forms

2. Active Ingredient Preparation
a) Intermediates & Preparation Thereof
b) Final Synthetic Stages
c) Complete Synthesis
d) Purification Methods
e) Fermentation Methods
f) Biotechnology

3. Formulations & Methods Thereof
a) General Formulations & Methods
b) Injectable Formulations
c) Oral Formulations
d) Other Administration-Specific Formulations
e) Excipients, Kits & Packaging

4. Related Medical Use & Administration
a) New Use Related to Main Indication
b) Dosing Regimen/Administration Conditions

5. Active Ingredient Combinations
a) Novel Combinations
b) Use of Combinations
c) Dosing Regimen & Administration Conditions for Combinations

6. Analytical Methods
a) Assaying Methods
b) Methods of Determining Patient Suitability

Search coverage:
Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.

Patent and national register access:
Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:
Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgements where available.

Updating:
To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:
You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Reporting and access:
All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'.


Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite.
Table of Content

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Diagnostic Electrocardiograph (DECG) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
An electrocardiograph is a non-invasive diagnostic device which is used in measuring the electrical activity of the heart. It is primarily used for the detection of cardiac problems in the patient. The global diagnostic electrocardiograph (DECG) market will undergo fair growth in the near future owing to factors such as the need for early detection of diseases, rise in incidence of lifestyle related diseases and increase in the standard of healthcare services. Due to  improvements in the field of medical technology, errors in diagnosis of diseases have been considerably...
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatological diagnostics market accounting for 28.7% of the total therapeutics market followed by psoriasis (26.4%), rosacea (14.9%), and atopic dermatitis (9%).  Many new players are emerging in this market as a result of a number of growth opportunities provided by this market, thus...
Organic Solar Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
A solar cell is a device that captures solar energy and converts the light energy into electricity using organic electronics.  This is done due to the photovoltaic characteristics of the solar cell that helps in converting the light energy into electricity. Organic solar cell use is one of the recent developments in this field. It holds the potential to reduce the overall cost involved in manufacturing and installing of silicon solar cells. Organic solar cells are manufactured from thinner films of organic semiconductors that comprise of polyphenylene vinylene and tiny...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...